Logo

Therapeutic Oligonucleotides — Antisense, RNAi, Triple-Helix, Enhancer-Decoy, CpG, and NA Chips

Oct 09, 2003
Premium

The New York Academy of Sciences has scheduled for publication next month a new book entitled Therapeutic Oligonucleotides — Antisense, RNAi, Triple-Helix, Enhancer-Decoy, CpG, and NA Chips.

The book is edited by the National Cancer Institute’s Y.S. Cho-Chung, and is concerned with “various aspects of oligonucleotides … [that] can modify gene-specific expression within cells and can identify genes involved in diseases,” according to NYAS.

The book is to sell for $130.

Details about ordering the book can be found at http://www.nyas.org /publications/annals/ann_sum.cfm?ID=936.

Filed under

Gene Silencing/Gene Editing
RNAi
Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.